Press Releases

  • 12/05/2023

CorWave announces the appointment of Fairuz Hasni as Vice President Human Resources

  • 10/09/2023

CorWave announces the grand opening of its manufacturing facility on the banks of the Seine, next to Paris

 

  • 09/26/2023

CorWave Announces the Appointment of Magalie Durrèche as Chief Financial Officer 

 

  • 06/20/2023

CorWave Announces Second Closing of Its Series C Funding at €61MTo Finance Its First Industrial Deployment

 

  • 03/17/2022

CorWave To Set Up Its Manufacturing Facility and Expand To A New Site Next to Paris.

 

  • 10/19/2021

CorWave Wins 2021 HealthTech Award.

 

  • 09/21/2021

CorWave Attracts Global Talent, Strengthening Its Management Team in Preparation for Clinical Phase and Industrial Ramp Up.

 

 

  • 06/14/2021

CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting.

 

  • 04/27/2021

CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation.

 

  • 02/08/2021

CorWave Joins the French Tech 120 Index, a Community That Brings Together the Top French Tech Scale-up Companies.

 

  • 01/06/2021

CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor.

 

  • 11/19/2020

CorWave Secures a €500,000 Grant From the Paris Region for Its Industrial Facilities.

 

  • 07/21/2020

CorWave Awarded €2.5M From the European Commission Through the EIC Accelerator Program.

 

  • 06/10/2020

CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting.

 

  • 02/11/2020

CorWave Appoints Jim Schuermann as an Independent Director.

 

  • 09/11/2019

CorWave Presented First Successful In Vivo 60-Day Study on Its Innovative LVAD Cardiac Support Device.

 

  • 06/28/2019

CorWave To Report First Successful In Vivo Survival at 30-Day Milestone with Its Innovative LVAD Cardiac Support Device.

 

  • 07/10/2018

CorWave’s next-generation LVAD receives funding.

 

  • 05/07/2018

Corwave Announces Issuance of US Patent Covering Its Implantable Left Ventricular Assist Device Leveraging the Wave Membrane Technology.

 

  • 03/16/2018

CorWave scales up increasing its R&D capabilities and opening a pilot production unit at its new Clichy site.

 

  • 03/15/2018

CorWave is pegged as a potential billion-euro company as part of “Future Unicorn” competition.

 

  • 03/14/2018

CorWave is set to receive about €3 million in financing through France’s Worldwide Innovation Challenge for its NovaPulse program, a mini-invasive solution for cardiac support.

 

  • 11/08/2017

CorWave Receives 2017 Deloitte ‘Technology Fast 50 Biotech of the Future’ Award of the Parisian Region.

 

  • 11/04/2016

CorWave Raises $17.1 Million in Series B Financing.

 

  • 07/22/2016

CorWave Awarded at the Worldwide Innovation Challenge.

 

  • 12/08/2015

CorWave Presents Promising Early Results for Innovative Wave Membrane Blood Pump.